Home LiteratureArticle Details
PMID: 8230466 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1.

Journal of virology ·Vol. 67 ·No. 12 ·1993-12-00 ·Pages 7450-60

Demarchi F, D'Agaro P, Falaschi A, Giacca M

Abstract

The regulation of the rate of transcription of human immunodeficiency virus type 1 is mainly exerted through the long terminal repeat (LTR) at the 5' end of the provirus. A large number of cis-acting regulatory elements have been identified in the LTR by in vitro binding studies; the biological role of these sites within living infected cells, however, is still not clear. We have studied the interactions of nuclear proteins with the LTR in the U1 monocytic cell line by in vivo dimethylsulfate footprinting, using the ligation-mediated polymerase chain reaction technique. In this cell line, transcription of the virus, which is very low under basal conditions, is highly inducible by treatment with phorbol esters; therefore, this system is likely to represent a suitable cellular model to study viral latency. Independently of the level of viral transcription, major in vivo footprints appear at the two Sp1 sites adjacent to the enhancer, the downstream-positioned enhancer repeat, the NFAT binding site, and one of the purine-rich sites of the negative regulatory element. Upon transcriptional activation by phorbol myristate acetate, the only perturbation in the footprinting pattern is a dramatic increase in dimethylsulfate sensitivity of guanine at position -92 in the downstream enhancer repeat. This modification is correlated with the transient induction of two enhancer-binding activities, as determined by gel retardation assays. While the transcriptional rate is still increasing and the in vivo footprinting pattern is unchanged at up to 24 h postactivation, these enhancer-binding factors are considerably reduced at this time. Therefore, further levels of regulation have to be considered to explain the maintenance of the induced state.

MeSH Terms
Base Sequence Cell Division/drug effects Cell Line DNA-Binding Proteins/metabolism Gene Expression Regulation, Viral HIV Core Protein p24/analysis HIV Long Terminal Repeat/genetics HIV-1/genetics Humans Molecular Sequence Data Monocytes/cytology Polymerase Chain Reaction Tetradecanoylphorbol Acetate/pharmacology Transcription, Genetic Virus Activation/genetics Virus Latency/genetics
Chemicals
DNA-Binding Proteins HIV Core Protein p24 Tetradecanoylphorbol Acetate
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Demarchi F
International Centre for Genetic Engineering and Biotechnology, Trieste.
D'Agaro P
Falaschi A
Giacca M
References (60)
60 references, click to expand
  1. Establishment and characterization of a human histiocytic lymphoma cell line (U-937).
    Int J Cancer. 1976 May 15;17(5):565-77 PMID: 178611
  2. Specific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription.
    J Virol. 1992 Jun;66(6):3883-7 PMID: 1583734
  3. Sequencing end-labeled DNA with base-specific chemical cleavages.
    Methods Enzymol. 1980;65(1):499-560 PMID: 6246368
  4. Regulation of human interleukin-2 gene: functional DNA sequences in the 5' flanking region for the gene expression in activated T lymphocytes.
    Cell. 1986 Aug 1;46(3):401-5 PMID: 3015413
  5. Activation of oncogenicity of the c-rel proto-oncogene.
    Mol Cell Biol. 1986 Dec;6(12):4709-16 PMID: 3025667
  6. Protein-DNA interactions in vivo upstream of a cell cycle-regulated human H4 histone gene.
    Science. 1987 Jun 5;236(4806):1308-11 PMID: 3035717
  7. Cell type-specificity elements of the immunoglobulin heavy chain gene enhancer.
    EMBO J. 1987 May;6(5):1323-30 PMID: 3038516
  8. Genomic footprinting reveals cell type-specific DNA binding of ubiquitous factors.
    Cell. 1987 Nov 6;51(3):435-43 PMID: 2889531
  9. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.
    Science. 1987 Nov 6;238(4828):800-2 PMID: 3313729
  10. Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.
    Science. 1987 Dec 11;238(4833):1575-8 PMID: 2825351
  11. Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter.
    Proc Natl Acad Sci U S A. 1988 Feb;85(3):723-7 PMID: 3422454
  12. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate.
    J Immunol. 1988 Feb 15;140(4):1117-22 PMID: 2449497
  13. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.
    Proc Natl Acad Sci U S A. 1988 Jul;85(13):4700-4 PMID: 3133660
  14. Identification and purification of EBP1: a HeLa cell protein that binds to a region overlapping the 'core' of the SV40 enhancer.
    Genes Dev. 1988 Aug;2(8):991-1002 PMID: 2844627
  15. I kappa B: a specific inhibitor of the NF-kappa B transcription factor.
    Science. 1988 Oct 28;242(4878):540-6 PMID: 3140380
  16. Structure-independent DNA amplification by PCR using 7-deaza-2'-deoxyguanosine.
    Nucleic Acids Res. 1988 Oct 25;16(20):9869 PMID: 3186456
  17. NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats.
    Trends Biochem Sci. 1992 Apr;17(4):135-40 PMID: 1533967
  18. Cellular transcription factors involved in the regulation of HIV-1 gene expression.
    AIDS. 1992 Apr;6(4):347-63 PMID: 1616633
  19. Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells.
    J Virol. 1992 Oct;66(10):6213-9 PMID: 1527859
  20. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS.
    J Virol. 1992 Dec;66(12):7328-35 PMID: 1433521
  21. The kappa B enhancer motifs in human immunodeficiency virus type 1 and simian virus 40 recognize different binding activities in human Jurkat and H9 T cells: evidence for NF-kappa B-independent activation of the kappa B motif.
    J Virol. 1992 Dec;66(12):7490-8 PMID: 1331533
  22. Characterization and purification of a novel transcriptional repressor from HeLa cell nuclear extracts recognizing the negative regulatory element region of human immunodeficiency virus-1 long terminal repeat.
    J Biol Chem. 1992 Dec 15;267(35):24948-52 PMID: 1459999
  23. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.
    Nature. 1993 Mar 25;362(6418):355-8 PMID: 8455722
  24. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.
    Nature. 1993 Mar 25;362(6418):359-62 PMID: 8096068
  25. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
    Science. 1993 Mar 19;259(5102):1749-54 PMID: 8096089
  26. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.
    Science. 1993 Mar 26;259(5103):1912-5 PMID: 8096091
  27. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease.
    J Virol. 1992 Jan;66(1):310-6 PMID: 1727491
  28. Contingent genetic regulatory events in T lymphocyte activation.
    Science. 1989 Jan 20;243(4889):355-61 PMID: 2783497
  29. Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B.
    Nature. 1989 May 4;339(6219):70-3 PMID: 2654643
  30. Regulatory pathways governing HIV-1 replication.
    Cell. 1989 Aug 11;58(3):423-6 PMID: 2569361
  31. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression.
    J Virol. 1989 Sep;63(9):3708-13 PMID: 2760980
  32. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR.
    Science. 1989 Nov 10;246(4931):780-6 PMID: 2814500
  33. The SV40 TC-II(kappa B) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non-lymphoid cell lines.
    EMBO J. 1989 Dec 20;8(13):4215-27 PMID: 2556265
  34. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.
    Proc Natl Acad Sci U S A. 1990 Jan;87(2):782-5 PMID: 2300561
  35. A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genes.
    Mol Cell Biol. 1990 Apr;10(4):1406-14 PMID: 2108316
  36. Genomic footprinting: detection of putative regulatory proteins in the promoter region of the interferon alpha-1 gene in normal human tissues.
    Mol Cell Biol. 1990 Jun;10(6):2554-61 PMID: 2342457
  37. Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors.
    Cell. 1990 Jun 29;61(7):1199-208 PMID: 2163758
  38. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.
    Cell. 1990 Jun 29;61(7):1271-6 PMID: 2364429
  39. Inducible nuclear factor binding to the kappa B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner.
    J Virol. 1990 Aug;64(8):4037-41 PMID: 2196387
  40. Highly conserved core domain and unique N terminus with presumptive regulatory motifs in a human TATA factor (TFIID).
    Nature. 1990 Jul 26;346(6282):387-90 PMID: 2374612
  41. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells.
    J Virol. 1990 Sep;64(9):4306-12 PMID: 2200885
  42. The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.
    Cell. 1990 Nov 16;63(4):803-14 PMID: 2225078
  43. The NF-kappa B transcription factor induces DNA bending which is modulated by its 65-kD subunit.
    Nucleic Acids Res. 1990 Nov 25;18(22):6497-502 PMID: 2174540
  44. Induction of human immunodeficiency virus type 1 expression in chronically infected cells is associated primarily with a shift in RNA splicing patterns.
    J Virol. 1991 Mar;65(3):1291-303 PMID: 1995944
  45. An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators.
    Mol Cell Biol. 1991 Apr;11(4):1883-93 PMID: 2005886
  46. A mediator required for activation of RNA polymerase II transcription in vitro.
    Nature. 1991 Apr 4;350(6317):436-8 PMID: 2011193
  47. HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes.
    Nature. 1991 Apr 25;350(6320):709-12 PMID: 2023633
  48. Modulation of HIV-enhancer activity by heterologous agents: a minireview.
    Gene. 1991 May 30;101(2):165-70 PMID: 2055485
  49. Cell-type specific multiprotein complex formation over the c-fos serum response element in vivo: ternary complex formation is not required for the induction of c-fos.
    Nucleic Acids Res. 1991 Jul 11;19(13):3607-11 PMID: 1906604
  50. Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.
    Nature. 1991 Aug 22;352(6337):733-6 PMID: 1876189
  51. Cloning of a cellular factor, interleukin binding factor, that binds to NFAT-like motifs in the human immunodeficiency virus long terminal repeat.
    Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7739-43 PMID: 1909027
  52. Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts.
    Mol Cell Biol. 1991 Oct;11(10):4943-51 PMID: 1922027
  53. Probing the nature of chromosomal DNA-protein contacts by in vivo footprinting.
    Biotechniques. 1991 Aug;11(2):188-90, 192-4, 196 passim PMID: 1931017
  54. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1.
    J Virol. 1991 Dec;65(12):6790-9 PMID: 1942252
  55. Glucocorticoid receptor-binding site in the human immunodeficiency virus long terminal repeat.
    J Virol. 1992 Jan;66(1):586-90 PMID: 1727502
  56. A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1.
    Virology. 1992 Jan;186(1):133-47 PMID: 1727595
  57. Effects of different DNA polymerases in ligation-mediated PCR: enhanced genomic sequencing and in vivo footprinting.
    Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):1021-5 PMID: 1736283
  58. Activation of human immunodeficiency virus type 1 provirus in T-cells and macrophages is associated with induction of inducer-specific NF-kappa B binding proteins.
    Virology. 1992 Mar;187(1):63-72 PMID: 1371030
  59. Probing protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1 by in vivo footprinting.
    J Virol. 1992 Apr;66(4):2514-8 PMID: 1548776
  60. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
    Biochemistry. 1979 Nov 27;18(24):5294-9 PMID: 518835
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1993-12-00
Pages
7450-60
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC238211
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]